English

TITAN MEDICAL INC

EDGAR

TMDI Report (type unavailable) · filed 2023-04-04

226 filing records in this dataset, filed from 2018-06-28 to 2023-04-04. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

10 million USD

2021 Q4 · USD

Exact inputs and evidence

Revenue: 20093000 USD Source
Revenue: 10093000 USD Source

Operating cash flow

-12.3 million USD

2021 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -36617000 USD Source
Operating Cash Flow: -24322000 USD Source

Free cash flow

-12.3 million USD

2021 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -36617000 USD Source
Operating Cash Flow: -24322000 USD Source
Capital Expenditure: 370000 USD Source
Capital Expenditure: 333000 USD Source

Cash and cash equivalents: 11.6 million USD 2022-09-30 Source
Exact value

11636000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

20.1 million USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Revenue: 50000 USD · 2021-01-01 – 2021-03-31 Source
Revenue: 10043000 USD · 2021-04-01 – 2021-06-30 Source
Revenue: 10093000 USD · 2021-01-01 – 2021-09-30 Source
Revenue: 10093000 USD · 2021-01-01 – 2021-06-30 Source
Revenue: 20093000 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 10093000 USD · 2021-01-01 – 2021-09-30 Source

Operating cash flow

-32 million USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Operating cash flow: -36617000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -24322000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -1925000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -11454000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -1925000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -19676000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -11454000 USD · 2022-01-01 – 2022-06-30 Source

Capital expenditure

511 thousand USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Capital expenditure: 370000 USD · 2021-01-01 – 2021-12-31 Source
Capital expenditure: 333000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 106000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 334000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 106000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 474000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 334000 USD · 2022-01-01 – 2022-06-30 Source

Free cash flow

-32.5 million USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Operating cash flow: -36617000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -24322000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -1925000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -11454000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -1925000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -19676000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -11454000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 370000 USD · 2021-01-01 – 2021-12-31 Source
Capital expenditure: 333000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 106000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 334000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 106000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 474000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 334000 USD · 2022-01-01 – 2022-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-04-04.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2021-12-31
Operating income: 3 of 11 periods available· newest 2021-12-31
net income: No compatible figures in this window
Operating cash flow: 5 of 11 periods available· newest 2021-12-31
Capital expenditure: 3 of 11 periods available· newest 2021-12-31
Total assets: 5 of 11 periods available· newest 2021-12-31
Total liabilities: 5 of 11 periods available· newest 2021-12-31
Current assets: 5 of 11 periods available· newest 2021-12-31
Current liabilities: 4 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2021-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+0.5%

Prior period

USD 20 million

2020-01-01 – 2020-12-31
Current period

USD 20.09 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

20093000 − 20000000 = 93000 USD

20000000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
20093000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · TITAN MEDICAL INC · 2021-12-31 TITAN MEDICAL INC (edgar:840551) Year-over-year change in Revenue: 93000 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 20093000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1331741 Filing: 000089109222001024 Input fundies:Revenue: 20000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1332622 Filing: 000089109222001024
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 35.77 million

Prior period

−USD 845,000

2020-01-01 – 2020-12-31
Current period

−USD 36.62 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-36617000 − -845000 = -35772000 USD

-845000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-36617000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · TITAN MEDICAL INC · 2021-12-31 TITAN MEDICAL INC (edgar:840551) Year-over-year change in Operating cash flow: -35772000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -36617000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1467802 Filing: 000089109222001024 Input fundies:OperatingCashFlow: -845000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1468922 Filing: 000089109222001024
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+32.1%

Prior period

USD 280,000

2020-01-01 – 2020-12-31
Current period

USD 370,000

2021-01-01 – 2021-12-31

Exact inputs and evidence

370000 − 280000 = 90000 USD

280000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
370000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · TITAN MEDICAL INC · 2021-12-31 TITAN MEDICAL INC (edgar:840551) Year-over-year change in Capital expenditure: 90000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 370000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1507901 Filing: 000089109222001024 Input fundies:CapitalExpenditure: 280000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1508897 Filing: 000089109222001024
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 20.09 million 100% of revenue
Operating costs Derived USD 51.08 million 254% of revenue
Operating income −USD 30.99 million −154% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow −USD 36.62 million −182% of revenue
Capital expenditure USD 370,000 1.8% of revenue
Free cash flow Derived −USD 36.99 million −184% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	0	Unavailable	Unavailable	Unavailable	Unavailable	-19092287 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -19088860 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 3427 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	0	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -41396777 USD Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	0	59266000 Derived	-59266000	Unavailable	Unavailable	Unavailable	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -59266000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -45961000 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	20000000	15849000 Derived	4151000	Unavailable	Unavailable	-1125000 Derived	Source 2020-01-01 – 2020-12-31: 20000000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 4151000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -845000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 280000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	20093000	51080000 Derived	-30987000	Unavailable	Unavailable	-36987000 Derived	Source 2021-01-01 – 2021-12-31: 20093000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -30987000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -36617000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 370000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 20.1M 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	0	Revenue: 0 Open source
20192019-12-31	Revenue	0	Revenue: 0 Open source
20202020-12-31	Revenue	20000000	Revenue: 20000000 Open source
20212021-12-31	Revenue	20093000	Revenue: 20093000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

0.5% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20192019-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20202020-12-31	Year over year	No prior comparable period	Revenue: 20000000 Open source Revenue: 0 Open source
20212021-12-31	Year over year	0.5%	Revenue: 20093000 Open source Revenue: 20000000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -154.2% 2021

Free cash flow margin -184.1% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2017-12-31	Operating margin	Not reported	Revenue: 0 Open source
2018-12-31	Operating margin	Not reported	Revenue: 0 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -59266000 Open source Revenue: 0 Open source
20202020-12-31	Operating margin	20.8%	Operating Income: 4151000 Open source Revenue: 20000000 Open source
20212021-12-31	Operating margin	-154.2%	Operating Income: -30987000 Open source Revenue: 20093000 Open source
2017-12-31	Net margin	Not reported	Revenue: 0 Open source
2018-12-31	Net margin	Not reported	Revenue: 0 Open source
2019-12-31	Net margin	Not reported	Revenue: 0 Open source
2020-12-31	Net margin	Not reported	Revenue: 20000000 Open source
2021-12-31	Net margin	Not reported	Revenue: 20093000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -19088860 Open source Capital Expenditure: 3427 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -41396777 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -45961000 Open source
20202020-12-31	Free cash flow margin	-5.6%	Revenue: 20000000 Open source Operating Cash Flow: -845000 Open source Capital Expenditure: 280000 Open source
20212021-12-31	Free cash flow margin	-184.1%	Revenue: 20093000 Open source Operating Cash Flow: -36617000 Open source Capital Expenditure: 370000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -36.6M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-19088860	Operating Cash Flow: -19088860 Open source
20182018-12-31	Operating cash flow	-41396777	Operating Cash Flow: -41396777 Open source
20192019-12-31	Operating cash flow	-45961000	Operating Cash Flow: -45961000 Open source
20202020-12-31	Operating cash flow	-845000	Operating Cash Flow: -845000 Open source
20212021-12-31	Operating cash flow	-36617000	Operating Cash Flow: -36617000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -37M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-19092287	Operating Cash Flow: -19088860 Open source Capital Expenditure: 3427 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -41396777 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -45961000 Open source
20202020-12-31	Free cash flow	-1125000	Operating Cash Flow: -845000 Open source Capital Expenditure: 280000 Open source
20212021-12-31	Free cash flow	-36987000	Operating Cash Flow: -36617000 Open source Capital Expenditure: 370000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

25.3% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	67.6%	Total Liabilities: 20067812 Open source Total Assets: 29674610 Open source
20182018-12-31	Liabilities / assets	80.8%	Total Liabilities: 17698055 Open source Total Assets: 21915164 Open source
20192019-12-31	Liabilities / assets	445.5%	Total Liabilities: 15063412 Open source Total Assets: 3381581 Open source
20202020-12-31	Liabilities / assets	146.3%	Total Liabilities: 43647000 Open source Total Assets: 29838000 Open source
20212021-12-31	Liabilities / assets	25.3%	Total Liabilities: 11929000 Open source Total Assets: 47222000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.01× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	Not reported	Current Assets: 28893671 Open source
20182018-12-31	Current assets / current liabilities	1.17×	Current Assets: 20742679 Open source Current Liabilities: 17698055 Open source
20192019-12-31	Current assets / current liabilities	0.12×	Current Assets: 1749442 Open source Current Liabilities: 15055411 Open source
20202020-12-31	Current assets / current liabilities	0.63×	Current Assets: 26948000 Open source Current Liabilities: 42896000 Open source
20212021-12-31	Current assets / current liabilities	4.01×	Current Assets: 43662000 Open source Current Liabilities: 10892000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	Unavailable Not reported for this period.	−USD 19.09 million Exact value Exact value: -19088860 USD 2017-01-01 – 2017-12-31: -19088860 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TITAN MEDICAL INC · 2017-12-31 TITAN MEDICAL INC (edgar:840551) Operating Cash Flow: -19088860 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19088860 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000119312520095647/tmdi-20181231.xml#116690 Filing: 000119312520095647 The citation records this snapshot. The page link may show a newer release later.	USD 3,427 Exact value Exact value: 3427 USD 2017-01-01 – 2017-12-31: 3427 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TITAN MEDICAL INC · 2017-12-31 TITAN MEDICAL INC (edgar:840551) Capital Expenditure: 3427 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3427 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000119312520095647/tmdi-20181231.xml#122984 Filing: 000119312520095647 The citation records this snapshot. The page link may show a newer release later.	−USD 19.09 million Calculation and evidence -19088860 − 3427 USD Exact free cash flow: -19092287 USD 2017-01-01 – 2017-12-31: -19088860 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 3427 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TITAN MEDICAL INC · 2017-12-31 TITAN MEDICAL INC (edgar:840551) Free cash flow: -19092287 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19088860 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000119312520095647/tmdi-20181231.xml#116690 Filing: 000119312520095647 Input fundies:CapitalExpenditure: 3427 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000119312520095647/tmdi-20181231.xml#122984 Filing: 000119312520095647 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	Unavailable Not reported for this period.	−USD 41.4 million Exact value Exact value: -41396777 USD 2018-01-01 – 2018-12-31: -41396777 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TITAN MEDICAL INC · 2018-12-31 TITAN MEDICAL INC (edgar:840551) Operating Cash Flow: -41396777 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41396777 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000115752320000839/tmdi-20191231.xml#179575 Filing: 000115752320000839 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	Unavailable Not reported for this period.	−USD 45.96 million Exact value Exact value: -45961000 USD 2019-01-01 – 2019-12-31: -45961000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TITAN MEDICAL INC · 2019-12-31 TITAN MEDICAL INC (edgar:840551) Operating Cash Flow: -45961000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45961000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1469991 Filing: 000089109222001024 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	Unavailable Not reported for this period.	−USD 845,000 Exact value Exact value: -845000 USD 2020-01-01 – 2020-12-31: -845000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TITAN MEDICAL INC · 2020-12-31 TITAN MEDICAL INC (edgar:840551) Operating Cash Flow: -845000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -845000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1468922 Filing: 000089109222001024 The citation records this snapshot. The page link may show a newer release later.	USD 280,000 Exact value Exact value: 280000 USD 2020-01-01 – 2020-12-31: 280000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TITAN MEDICAL INC · 2020-12-31 TITAN MEDICAL INC (edgar:840551) Capital Expenditure: 280000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 280000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1508897 Filing: 000089109222001024 The citation records this snapshot. The page link may show a newer release later.	−USD 1.13 million Calculation and evidence -845000 − 280000 USD Exact free cash flow: -1125000 USD 2020-01-01 – 2020-12-31: -845000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 280000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TITAN MEDICAL INC · 2020-12-31 TITAN MEDICAL INC (edgar:840551) Free cash flow: -1125000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -845000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1468922 Filing: 000089109222001024 Input fundies:CapitalExpenditure: 280000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1508897 Filing: 000089109222001024 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	Unavailable Not reported for this period.	−USD 36.62 million Exact value Exact value: -36617000 USD 2021-01-01 – 2021-12-31: -36617000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TITAN MEDICAL INC · 2021-12-31 TITAN MEDICAL INC (edgar:840551) Operating Cash Flow: -36617000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36617000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1467802 Filing: 000089109222001024 The citation records this snapshot. The page link may show a newer release later.	USD 370,000 Exact value Exact value: 370000 USD 2021-01-01 – 2021-12-31: 370000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TITAN MEDICAL INC · 2021-12-31 TITAN MEDICAL INC (edgar:840551) Capital Expenditure: 370000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 370000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1507901 Filing: 000089109222001024 The citation records this snapshot. The page link may show a newer release later.	−USD 36.99 million Calculation and evidence -36617000 − 370000 USD Exact free cash flow: -36987000 USD 2021-01-01 – 2021-12-31: -36617000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 370000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TITAN MEDICAL INC · 2021-12-31 TITAN MEDICAL INC (edgar:840551) Free cash flow: -36987000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:13:01Z Snapshot: 7f8ea3cb6198bf91608b6c1826151b83f707b828dc24aac2f2dd78a4d7ed6be3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/840551?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36617000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1467802 Filing: 000089109222001024 Input fundies:CapitalExpenditure: 370000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/840551/000089109222001024/tmdi20f1221.htm#1507901 Filing: 000089109222001024 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

226 filings · 674 latest values · 674 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000840551, 840551, TMDI, edgar:840551

Also known as TITAN MEDICAL INC, Titan Medical Inc, Titan Medical Inc.

TITAN MEDICAL INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation